BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 31366495)

  • 1. Low IRBIT Levels Are Associated With Chemo-resistance in Gastric Cancer Patients.
    Nakazawa N; Ogata K; Yokobori T; Ide M; Baatar S; Ubukata Y; Kimura A; Kogure N; Sohda M; Kuwano H; Saeki H; Shirabe K
    Anticancer Res; 2019 Aug; 39(8):4111-4116. PubMed ID: 31366495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
    Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer.
    Yang L; Yang S; Liu J; Wang X; Ji J; Cao Y; Lu K; Wang J; Gao Y
    Exp Mol Pathol; 2014 Apr; 96(2):235-41. PubMed ID: 24602846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of
    Katayama Y; Oshima T; Sakamaki K; Aoyama T; Sato T; Masudo K; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
    In Vivo; 2017; 31(4):565-571. PubMed ID: 28652421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IRBIT homologue lacks binding activity to inositol 1,4,5-trisphosphate receptor due to the unique N-terminal appendage.
    Ando H; Mizutani A; Mikoshiba K
    J Neurochem; 2009 Apr; 109(2):539-50. PubMed ID: 19220705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRBIT Interacts with the Catalytic Core of Phosphatidylinositol Phosphate Kinase Type Iα and IIα through Conserved Catalytic Aspartate Residues.
    Ando H; Hirose M; Gainche L; Kawaai K; Bonneau B; Ijuin T; Itoh T; Takenawa T; Mikoshiba K
    PLoS One; 2015; 10(10):e0141569. PubMed ID: 26509711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy.
    Omura T; Shimada Y; Nagata T; Okumura T; Fukuoka J; Yamagishi F; Tajika S; Nakajima S; Kawabe A; Tsukada K
    Oncol Rep; 2014 Feb; 31(2):613-8. PubMed ID: 24317477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splicing variation of Long-IRBIT determines the target selectivity of IRBIT family proteins.
    Kawaai K; Ando H; Satoh N; Yamada H; Ogawa N; Hirose M; Mizutani A; Bonneau B; Seki G; Mikoshiba K
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3921-3926. PubMed ID: 28348216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1alpha expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancer.
    Nakamura J; Kitajima Y; Kai K; Mitsuno M; Ide T; Hashiguchi K; Hiraki M; Miyazaki K
    Oncol Rep; 2009 Oct; 22(4):693-9. PubMed ID: 19724845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Int J Cancer; 2010 Sep; 127(5):1158-71. PubMed ID: 20020496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GRP78 expression in gastric cancer and its clinical significance].
    Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy.
    Wu X; Zhou F; Ji X; Ren K; Shan Y; Mao X; Fen Y; Chen R; Ding H; Fu X
    Future Oncol; 2017 Dec; 13(29):2691-2696. PubMed ID: 28972404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial.
    Oshima T; Tsuburaya A; Yoshida K; Yoshikawa T; Miyagi Y; Rino Y; Masuda M; Guan J; Tan P; Grabsch HI; Sakamoto J; Tanaka S
    Sci Rep; 2022 May; 12(1):8509. PubMed ID: 35595817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer.
    Pattison S; Mitchell C; Lade S; Leong T; Busuttil RA; Boussioutas A
    PLoS One; 2017; 12(9):e0183891. PubMed ID: 28922362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRBIT: a regulator of ion channels and ion transporters.
    Ando H; Kawaai K; Mikoshiba K
    Biochim Biophys Acta; 2014 Oct; 1843(10):2195-204. PubMed ID: 24518248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of Tensin 4 Gene Expression in Patients with Gastric Cancer.
    Sawazaki S; Oshima T; Sakamaki K; Aoyama T; Sato T; Shiozawa M; Yoshikawa T; Rino Y; Imada T; Masuda M
    In Vivo; 2017; 31(6):1065-1071. PubMed ID: 29102927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
    Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
    Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Relevance of Postoperative Neutrophil-Lymphocyte Ratio (NLR) to Recurrence After Adjuvant Chemotherapy of S-1 for Gastric Cancer.
    Tanaka H; Tamura T; Toyokawa T; Muguruma K; Miki Y; Kubo N; Sakurai K; Hirakawa K; Ohira M
    Anticancer Res; 2018 Jun; 38(6):3745-3751. PubMed ID: 29848737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer.
    Norton N; Fox N; McCarl CA; Tenner KS; Ballman K; Erskine CL; Necela BM; Northfelt D; Tan WW; Calfa C; Pegram M; Colon-Otero G; Perez EA; Clynes R; Knutson KL
    Breast Cancer Res; 2018 Jun; 20(1):52. PubMed ID: 29898752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.